| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 08/08/2007 | CN101014589A Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/02/2007 | WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof |
| 08/01/2007 | EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 07/26/2007 | US20070173643 Process for Producing Cyclic Compounds |
| 07/26/2007 | US20070173486 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent; antidepressant; eating disorders, obesity, nicotine addiction, neuropathy, cognitive disorders, attention deficit disorder, stress, epilepsy, dementia, distonia, Alzheimer's |
| 07/25/2007 | EP1810693A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/25/2007 | EP1572628B1 Isophtalic acid derivatives |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2007 | CN1327766C Compounds, compositions, and methods for controlling biofilms |
| 07/24/2007 | US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport |
| 07/19/2007 | US20070167620 N-allyloxycarbonylmethylenetriphenphosphino- (3S,4S)-3-[(1R)-1-(t-Butyldimethylsilyloxy)ethyl]-4-[(1R)-1-carboxyethyl]- 2-azetidinone; crystallization |
| 07/19/2007 | US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 07/19/2007 | US20070167410 cyclic oximes useful in treatment or prevention of diseases mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction; 3-{[5-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-5,6,7,8-tetrahydro-naphthalen-2-ylmethyl]-amino}-propionic acid |
| 07/18/2007 | EP1807393A1 Diarylsulfones as 5-ht2a antagonists |
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/12/2007 | WO2007044318A3 Anti-hypercholesterolemic compounds |
| 07/12/2007 | US20070161622 Diamino alcohols and their use as renin inhibitor |
| 07/12/2007 | US20070161577 Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones |
| 07/11/2007 | CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives |
| 07/10/2007 | US7241902 for treatment of hypertension, elevated triglycerides, and elevated insulin |
| 07/10/2007 | US7241757 Amidino derivatives and their use as thrombin inhibitors |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155675 Substituted azetidinone compunds, processes for preparing the same, formulations and uses thereof |
| 07/05/2007 | US20070155674 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 07/04/2007 | EP1802571A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
| 07/03/2007 | US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 06/28/2007 | WO2007072088A1 Process for the production of ezetimibe and intermediates used in this proces |
| 06/28/2007 | US20070149776 Method for producing 1,4-diphenyl azetidinone derivatives |
| 06/28/2007 | US20070149501 Process for the preparation of diphenyl azetidinone derivatives |
| 06/28/2007 | CA2630737A1 Process for the production of ezetimibe and intermediates used in this process |
| 06/26/2007 | US7235543 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/21/2007 | US20070142304 Diphenylazetidinone derivatives possessing chloesterol absorption inhibitory activity |
| 06/20/2007 | EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/20/2007 | EP1663966B1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984888A Substituted azetidine compounds, their preparation and use as medicaments |
| 06/19/2007 | US7232812 Substituted azetidine compounds, their preparation and use as medicaments |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070135384 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| 06/14/2007 | US20070135357 Anti-hypercholesterolemic compounds |
| 06/13/2007 | EP1794129A2 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 06/13/2007 | CN1980892A Dpp-IV inhibitors |
| 06/07/2007 | US20070129540 Process for the preparation of chiral azetidinones |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/06/2007 | CN1976899A Regioselective functionalisation and protection of spirolactams |
| 06/06/2007 | CN1976898A Spirolactams and their synthesis |
| 06/06/2007 | CN1974568A Prepn process of aztreonam |
| 06/06/2007 | CN1974551A Process of synthesizing (2S-trans)-3-methyl-4-oxo-1-azacyclo butyl sulfonic acid |
| 05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | WO2007060484A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | WO2007059871A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
| 05/31/2007 | WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same |
| 05/31/2007 | WO2007030721A3 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 05/31/2007 | US20070123507 Process for converting heterocyclic ketones to amido-substituted heterocycles |
| 05/31/2007 | US20070123506 4-{4-[3-[3-(4-Fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylamino}butane-1-sulfonic acid; antilipemic, antidiabetic and hypoglycemic agents; insulin resistance |
| 05/31/2007 | CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | CA2630039A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | CA2629995A1 Chemical process for the preparation of an amido-phenoxybenzoic acid compound |
| 05/30/2007 | EP1789392A2 Preparation of pyridonecarboxylic acid antibacterials |
| 05/29/2007 | US7223859 carbamylation of (R)-4-ethyl-1-[4-(trifluoromethyl)phenyl]-2-azetidinone, with carbamic acid, methyl or benzyl esters, to form chemical intermediates for cholesteryl ester transfer protein inhibitors |
| 05/29/2007 | US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders |
| 05/24/2007 | DE102005054621A1 Preparation of 4-acyloxy azetidinone, useful as intermediate for synthesizing the class of penem antibiotics and as antibacterial agent, comprises oxidation of azetidinone with a peracid in presence of cobalt catalyst and a Bronsted-base |
| 05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 05/23/2007 | EP1385548B1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 05/22/2007 | US7220870 Resolution of epi(chloro or bromo)hydrin using transition metal catalyst |
| 05/22/2007 | US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists |
| 05/22/2007 | CA2436863C Process and ester derivatives useful for preparation of cephalosporins |
| 05/18/2007 | WO2006122020A3 Process for production of 4-biphenylyazetidin-2-ones |
| 05/16/2007 | EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 05/16/2007 | CN1315849C Derivant of cephalosporin alkene, and preparation method |
| 05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
| 05/10/2007 | WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/10/2007 | US20070105832 e.g. 3-((2-(di-t-butyloxycarbonylamino)pyridin-4-yl)methyl)-4-oxoazetidine-2-carboxylic acid; tryptase, thrombin, trypsin, Factor Xa, Factor VIIa, Factor XIa inhibitor; urokinase-type plasminogen activator; antiallergen; chronic asthma, allergic rhinitis, and thrombotic disorders |
| 05/10/2007 | US20070105831 Carboxamide derivatives as muscarinic receptor antagonists |
| 05/09/2007 | EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
| 05/08/2007 | US7214803 Amidation of an alpha-pyrrolidinonylalkanoate by reaction with ammonium hydroxide |
| 05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
| 05/08/2007 | US7214364 Antibiotic for gramnegative bacteria; atomized dry powder |
| 05/03/2007 | WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/02/2007 | CN1956968A Aryl glycinamide derivatives and their use as NK1 antagonists and 5-serotonin reuptake inhibithors |
| 05/02/2007 | CN1956951A Method for producing diphenyl azetidinone derivatives |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 04/26/2007 | WO2006108039A3 Substituted azetidinones |
| 04/26/2007 | US20070093469 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 04/25/2007 | CN1953961A Method for producing 1,4-diphenyl azetidinone derivatives |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208486 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 04/19/2007 | WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/19/2007 | WO2007044318A2 Anti-hypercholesterolemic compounds |
| 04/19/2007 | WO2007043939A1 Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a |
| 04/19/2007 | WO2007043938A1 NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B |